Frontiers in Aging Neuroscience (Sep 2022)

Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook

  • Rwei-Ling Yu,
  • Ruey-Meei Wu

DOI
https://doi.org/10.3389/fnagi.2022.943438
Journal volume & issue
Vol. 14

Abstract

Read online

Mild cognitive impairment (MCI) is one of the common non-motor symptoms in patients with Parkinson’s disease (PD). MCI is the transition stage between normal aging and full-blown dementia and is also a powerful predictor of dementia. Although the concept of MCI has been used to describe some of the PD symptoms for many years, there is a lack of consistent diagnostic criteria. Moreover, because of the diverse patterns of the cognitive functions, each cognitive impairment will have a different progression. In this review, we overviewed the diagnostic criteria for PD-MCI, primarily focused on the heterogeneity of PD-MCI patients’ cognitive function, including various types of cognitive functions and their progression rates. A review of this topic is expected to be beneficial for clinical diagnosis, early intervention, and treatment. In addition, we also discussed the unmet needs and future vision in this field.

Keywords